Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » OncoDNA Inks Contract With HalioDx to Expand Pharma Testing Services Into North America

OncoDNA Inks Contract With HalioDx to Expand Pharma Testing Services Into North America

Jan 07, 2021
|
staff reporter

NEW YORK – Belgium-based OncoDNA on Thursday said that it has signed a subcontract service agreement with HalioDx, which will allow it to expand its molecular testing services to pharmaceutical firms developing precision cancer therapies in North America.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Lander Nominated for Science Advisor

President-elect Joe Biden has nominated Eric Lander to serve as director of the Office of Science and Technology Policy, the Associated Press says.

What's It Called?

Nature News writes that scientists are trying to figure out how to name the new strains of SARS-CoV-2 that are emerging.

Twin COVID-19 Studies

The New York Times reports that researchers are studying identical twins who had COVID-19 to understand the influence of genetics on disease severity.

PNAS Papers on Positive Epistasis in Cystic Fibrosis, Tiger Rattlesnake Genome, More

In PNAS this week: epistasis affecting cystic fibrosis, Tiger rattlesnake genome gives venom insight, and more.

What's Popular?

In Business News

  1. Thermo Fisher Scientific to Acquire Mesa Biotech for Up to $550M

  2. Lucira Health Files for $115M IPO

  3. Ancestry to Discontinue NGS-Based AncestryHealth Service

  4. JP Morgan Healthcare Conference 2021, Day 3: Exact Sciences, Danaher, NanoString, Bio-Techne, More

  5. Pacific Biosciences CEO Discusses Q4 Results, New Sequencing Platforms at JP Morgan

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.